Literature DB >> 9403751

Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications.

T Ryan1, J F Mc Carthy, M Y Rady, J Serkey, S Gordon, N J Starr, D M Cosgrove.   

Abstract

OBJECTIVE: To determine the incidence, predisposing factors, and outcome of early bloodstream infection after cardiopulmonary bypass.
DESIGN: A case control study.
SETTING: A 54-bed cardiac surgical intensive care in a tertiary referral center. PATIENTS: Patients from a 30-month period with preoperative hospital stay of <48 hrs and subsequent bloodstream infection within 96 hrs of cardiopulmonary bypass were included in a case group. The control group consisted of patients who had cardiac surgery on the same day as the case group.
MEASUREMENTS AND MAIN RESULTS: Patient demographics, history of comorbidity, preoperative laboratory testing, details of surgery, transfusion requirement, inotropic infusions, hemodynamics, and arterial blood gases on admission to intensive care were compared in the two groups. Measures of outcome were duration of mechanical ventilation and intensive care stay, serum creatinine on the first postoperative day, highest creatinine and bilirubin concentrations, and hospital mortality. During the study period, 7,928 patients had cardiac surgery. Sixteen (0.2%) patients had early bloodstream infection; the control group consisted of 95 patients. Thirteen of the patients with bloodstream infection had Gram-negative bacilli on blood culture, two had Candida species, and two had Gram-positive bacteria. On multivariate logistic regression analysis, greater prevalence of preoperative pulmonary hypertension (odds ratio 9; 95% confidence interval 2 to 41.8; p = .004), diabetes (odds ratio 4.6; 95% confidence interval 1.4 to 15.8; p = .01), number of blood products transfused (odds ratio 1.09; 95% confidence interval 1.04 to 1.17; p = .005), and infusion of inotropes (odds ratio 4.7; 95% confidence interval 1.3 to 16.4; p = .02) or vasopressors (odds ratio 4.1; 95% confidence interval 1.3 to 15.6; p = .02) were associated with postoperative bloodstream infection. Early bloodstream infection was associated with significantly prolonged duration of mechanical ventilation (117.2 +/- 21.5 vs. 18 +/- 8.8 hrs; p = .0001), intensive care stay (213 +/- 27.5 vs. 53 +/- 11.3 hrs; p < .0001), greater creatinine concentrations on the first postoperative day (1.6 +/- 0.1 vs. 1.2 +/- 0.04 mg/dL; p = .0002), greater maximum creatinine concentration (2.4 +/- 0.2 vs. 1.3 +/- 0.1 mg/dL; p < .0001), and greater maximum bilirubin concentration (4.7 +/- 0.6 vs. 1.3 +/- 0.2 mg/dL; p < .0001) when compared with the control group. Five (32%) of 16 bacteremic patients died vs. none of the 95 control patients (p < .0001).
CONCLUSIONS: Early bloodstream infection after cardiac surgery is uncommon and involves predominantly Gram-negative bacteria. The risk factors associated with bloodstream infection were preoperative morbidity and more complex surgery. Bloodstream infection was associated with a significantly adverse impact on outcome after cardiac surgery.

Entities:  

Mesh:

Year:  1997        PMID: 9403751     DOI: 10.1097/00003246-199712000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Diabetes mellitus is an independent risk factor for ICU-acquired bloodstream infections.

Authors:  M Michalia; M Kompoti; A Koutsikou; A Paridou; P Giannopoulou; E Trikka-Graphakos; P Clouva-Molyvdas
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

2.  Serum value of procalcitonin as a marker of intestinal damages: type, extension, and prognosis.

Authors:  C Cosse; C Sabbagh; F Browet; F Mauvais; L Rebibo; E Zogheib; D Chatelain; S Kamel; J M Regimbeau
Journal:  Surg Endosc       Date:  2015-02-21       Impact factor: 4.584

Review 3.  Clinical aspects of invasive candidiasis: endocarditis and other localized infections.

Authors:  Mario Venditti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  Daptomycin and Its Immunomodulatory Effect: Consequences for Antibiotic Treatment of Methicillin-Resistant Staphylococcus aureus Wound Infections after Heart Surgery.

Authors:  Theodor Tirilomis
Journal:  Front Immunol       Date:  2014-03-11       Impact factor: 7.561

5.  Is type 2 diabetes mellitus in mechanically ventilated adult trauma patients potentially related to the occurrence of ventilator-associated pneumonia?

Authors:  Hadi Darvishi-Khezri; Abbas Alipour; Amir Emami Zeydi; Abolfazl Firouzian; Ghahraman Mahmudi; Melody Omrani-Nava
Journal:  J Res Med Sci       Date:  2016-04-08       Impact factor: 1.852

6.  Biological scoring system for early prediction of acute bowel ischemia after cardiac surgery: the PALM score.

Authors:  Elie Zogheib; Cyril Cosse; Charles Sabbagh; Simon Marx; Thierry Caus; Marc Henry; Joseph Nader; Mathurin Fumery; Michael Bernasinski; Patricia Besserve; Faouzi Trojette; Cedric Renard; Pierre Duhaut; Said Kamel; Jean-Marc Regimbeau; Hervé Dupont
Journal:  Ann Intensive Care       Date:  2018-04-18       Impact factor: 6.925

7.  CD62L (L-selectin) shedding for assessment of perioperative immune sensitivity in patients undergoing cardiac surgery with cardiopulmonary bypass.

Authors:  Gabor Erdoes; Maria L Balmer; Emma Slack; Istvan Kocsis; Lutz E Lehmann; Balthasar Eberle; Frank Stüber; Malte Book
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

8.  Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients.

Authors:  Franz Ratzinger; Michael Schuardt; Katherina Eichbichler; Irene Tsirkinidou; Marlene Bauer; Helmuth Haslacher; Dieter Mitteregger; Michael Binder; Heinz Burgmann
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

9.  Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia?--An observational study.

Authors:  Katharina Chalk; Christian Meisel; Claudia Spies; Thomas Volk; Karin Thuenemann; Jörg Linneweber; Klaus-Dieter Wernecke; Michael Sander
Journal:  Crit Care       Date:  2013-12-09       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.